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T
he tremendous medical promise of
gene therapy remains unmet due to
the lack of safe and eﬀective delivery
vehicles.1 Though regarded as eﬃcient
gene carriers, viral vectors are associated
with safety risks including insertional muta-
genesis and adverse immune responses.2
Nonviral gene vectors oﬀer the possibility of
improved safety but have generally failed to
attain satisfactory delivery eﬃcacy in clinical
testing.3,4 One challenge to the rational de-
sign of synthetic nanocarriers is the limited
understanding of the relationship between
nanoparticle structure and function, as
well as a lack of insight into the rate-limiting
steps and key cellular regulators aﬀecting
delivery eﬃcacy.5 Although several groups
are working toward characterization of dif-
ferent physicochemical parameters of nano-
medicines on cellular uptake, the endosomal
machinery involved in the internalization,
transport, and escape of nanoparticles to the
cytosol remains elusive.6,7
Cellular uptake of nanoparticles is critical
for intracellular delivery and has been the
subject of various studies.8 Typical endocy-
tic mechanisms include macropinocytosis,
clathrin-dependent endocytosis, caveolae-
mediated endocytosis, and a number of cla-
thrin- and caveolae-independent pathways
such as RhoA-dependent, Arf6-dependent,
Cdc42-dependent, and ﬂotillin-dependent
endocytosis.9 A handful of nanocarriers ap-
pear to rely predominantly on a single path-
way. Certain kinds of poly(lactic-co-glycolic
acid) (PLGA) nanoparticles, for instance, were
reported tobe internalizedby vascular smooth
muscle cells via clathrin-dependent endo-
cytosis,1012 whereas DOXIL and Abraxane
nanoparticles enter tumor cells via caveolae-
mediated endocytosis.13,14 Macropinocytosis,
meanwhile, appeared tobe themajorpathway
used for entry in HeLa cells by certain siRNA-
containing nanoparticles composed of lipid-
like materials (LNPs).15 However, for many
nanoparticles used for nonviral gene delivery,
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ABSTRACT Despite intensive research eﬀort, the rational design of improved
nanoparticulate drug carriers remains challenging, in part due to a limited
understanding of the determinants of nanoparticle entry and transport in target
cells. Recent studies have shown that Niemann-Pick C1 (NPC1), the lysosome
membrane protein that mediates traﬃcking of cholesterol in cells, is involved in
the endosomal escape and subsequent infection caused by ﬁloviruses, and that its
absence promotes the retention and eﬃcacy of lipid nanoparticles encapsulating
siRNA. Here, we report that NPC1 deﬁciency results in dramatic reduction in internalization and transfection eﬃciency mediated by degradable cationic
gene delivery polymers, poly(β-amino ester)s (PBAEs). PBAEs utilized cholesterol and dynamin-dependent endocytosis pathways, and these were found to
be heavily compromised in NPC1-deﬁcient cells. In contrast, the absence of NPC1 had minor eﬀects on DNA uptake mediated by polyethylenimine or
Lipofectamine 2000. Strikingly, stable overexpression of human NPC1 in chinese hamster ovary cells was associated with enhanced gene uptake (3-fold)
and transfection (10-fold) by PBAEs. These ﬁndings reveal a role of NPC1 in the regulation of endocytic mechanisms aﬀecting nanoparticle traﬃcking. We
hypothesize that in-depth understanding sites of entry and endosomal escape may lead to highly eﬃcient nanotechnologies for drug delivery.
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including poly-L-lysine (PLL) and polyethylenimine
(PEI)-based polyplexes, as well as various lipoplexes
and liposomes, evidence exists for cellular entry via
multiple endocytic mechanisms.1623
Poly(β-amino ester)s (PBAEs) are biodegradable cat-
ionic polymers that mediate gene delivery in a variety
of in vitro and in vivo contexts, including suicide gene
therapy of several animalmodels of cancer2426 as well
as genetic modiﬁcation of stem cells for treatment of
ischemia.27 These polymers have demonstrated super-
ior performance and less toxicity in several diﬃcult-to-
transfect cell types2830 compared to commercially
available transfection reagents such as Lipofectamine
2000 (LF 2000). The versatility of the polymerization
chemistry31 has allowed a broad set of structures to
be synthesized and screened in a high-throughput
manner,3236 permitting systematic investigation of
key parameters aﬀecting gene delivery potency such
as polymer molecular weight distribution,37 hydro-
phobicity of the side chains,38 and amine end-group
structure.3942 The endocytic mechanisms used by
PBAEs for internalization remain unreported.
Here, we show that while PBAE/DNA nanoparticles
appear to usemultiple pathways to enter cells, eﬃcient
cellular uptake and gene transfection depend on the
cholesterol transport function of Niemann-Pick C1
(NPC1). We have identiﬁed a unique traﬃcking path-
way selective to PBAEs that, upon being misregulated,
has a drastic eﬀect on the ability of the polymer to
deliver DNA inside cells. This study indicates that NPC1
plays an important role in regulating endocytic me-
chanisms aﬀecting internalization and eﬃcacy of cer-
tain nanoparticles.
RESULTS
Identification of U18666A as an Inhibitor of PBAE-Mediated
Gene Transfection. To assess the mechanisms of cellular
entry used by poly(β-amino ester)s, we screened a set
of inhibitors for their potential to reduce cellular inter-
nalization of fluorescently labeled DNA by C32122,
one of the top-performing amine end-modified PBAEs.
Immortalized mouse embryonic fibroblast (MEF) cells
were pretreated with various inhibitors for 1 h, then
transfected with C32122 polyplexes containing Cy5-
labeled DNA in the presence of these inhibitors. Based
on optimization experiments, the inhibitors were used
at concentrations below the threshold of inducing
notable cytotoxicity (data not shown). After 3 h, the
cells were washed multiple times, fixed, stained with
DAPI, and analyzed by high-throughput confocal micro-
scopy for cell-associated fluorescent signal (Figure 1a).
Treatment with inhibitors of clathrin-mediated
Figure 1. U18666A inhibits C32122-mediated uptake of DNA in MEFs. (a) MEFs were transfected with C32122 polyplexes
containing Cy3-labeled DNA in the presence of various endocytic pathway inhibitors (5 μMU18666A, 50 μM dynasore, 1 mM
methyl-β-cyclodextrin, 10 μM genistein, 5 μM ﬁlipin, 5 μM chlorpromazine, 10 μM EIPA). MEFs were pretreated with the
inhibitors 1 h prior to transfection. After 3 h, the cells were washed, ﬁxed, treated with a nuclear stain, and analyzed by high-
throughput confocal microscopy to quantify relative DNA uptake (mean ( SD, n = 3); * indicates p < 0.05, *** indicates
p < 0.001, compared to no drug control. (b) Relative DNA uptake eﬃciencies inMEFs (mean( SD, n = 3) as quantiﬁed by FACS
3 h following transfection of C32122/Cy5-labeled DNA in the presence of the indicated concentration of U18666A;
* indicates p < 0.05, ** indicates p < 0.01, compared to no drug control. (c) Overall MEF transfection eﬃciency (mean ( SD,
n = 4) as quantiﬁed by FACS 24 h following transfection of C32122/GFP-encoding DNA in the presence of 5 μM U18666A;
** indicates p < 0.01, *** indicates p < 0.001 for the comparisons indicated.
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endocytosis (chlorpromazine), macropinocytosis (EIPA),
and caveolae-mediated endocytosis (genistein, filipin,
and methyl-β-cyclodextrin) had no significant effect or
caused increased uptake, but treatment with dynasore,
an inhibitor of dynamin-dependent pathways including
clathrin-mediated and caveolae-mediated endocytosis,
significantly reduced relative DNA uptake mediated by
PBAEs. The significant increases in uptake observed for
some inhibitors such as EIPA and chlorpromazine sug-
gest that the cells may compensate for incomplete
suppression by promoting or upregulating alternate
endocytic pathways.43 However, DNA uptake was in-
hibited to the greatest extent in the presence of the
small molecule U18666A, an inhibitor of cholesterol
trafficking.
Using ﬂuorescence-activated cell sorting (FACS)
analysis, we quantiﬁed relative DNA uptake in these
cells following PBAE-based transfection in the pre-
sence of various doses of U18666A. U18666A treat-
ment was associated with dose-dependent reductions
in DNA internalization by C32122 (Figure 1b). To
determine if U18666A inhibits overall gene transfec-
tion by PBAEs, we transfected MEFs with various doses
of C32122 polyplexes containing GFP-encoding plas-
mid DNA in the presence of the inhibitor and assessed
GFP expression eﬃciency by FACS at 24 h. As expected,
U18666A substantially inhibited gene transfection by
C32122 (Figure 1c).
Studies with NPC1-Deficient Mouse Embryonic Fibroblasts.
Because U18666A inhibits cholesterol synthesis and
trafficking, we hypothesized that Niemann-Pick C1, an
endo/lysosomal protein involved in cholesterol traf-
ficking, may play a role in C32122-mediated DNA
transfection. Using MEF cell lines obtained from wild-
type or NPC1/mice, we compared gene transfection
efficiencies 1 day after treatment with C32122 poly-
plexes containing GFP-encoding plasmid DNA. Fluo-
rescence microscopy showed that, for equivalent
DNA doses, GFP expression was dramatically lower in
NPC1/MEFs relative to thewild-type cells (Figure 2a).
When FACS analysis was used to compare the
C32122/DNA doseresponse profiles of the two cell
lines, we observed that the ED50 concentration was
approximately 3-fold greater for theNPC1/ cells than
that for the wild-type cells (Figure 2b). Even more
strikingly, GFP expression levels of positively trans-
fected cells were reduced over 10-fold in NPC1 knock-
out cells (Figure 2c).
To determine whether NPC1 knockout reduces
DNA uptake by C32122, high-throughput confocal
microscopy was used to examine the ﬂuorescent
intensity levels of NPC1þ/þ and NPC1/ MEFs treated
withpolyplexes incorporatingCy3-labeledDNA (Figure3a).
We observed that NPC1 deﬁciency was associated with
signiﬁcantly (3-fold) decreased uptake across a range
of DNA doses tested (Figure 3b).
Characterization of Cy5-labeled DNA internaliza-
tion by FACS analysis conﬁrmed that NPC1 knockout
signiﬁcantly reduced both the eﬃciency and the ﬂuor-
escent intensity of MEFs transfected using C32122
(Figure 4). To determine whether NPC1 deﬁciency also
aﬀected DNA internalization mediated by other trans-
fection reagents, we conducted analogous experi-
ments with PEI and LF 2000. NPC1 knockout had no
signiﬁcant impact on labeled DNA uptake eﬃciency or
the overall uptake level by LF 2000, while NPC1 knock-
out was associated with a modest reduction in overall
uptake, but had little eﬀect on internalization eﬃciency
by PEI (Figure 4).
Studies with Markers of Endocytosis. We next assessed
the relative uptake of various known markers of
endocytic pathways in NPC1þ/þ and NPC1/ MEFs.
These markers included fluorescently labeled transfer-
rin, cholera toxin B, and 10 000 MW dextran, which
have been shown to undergo internalization via cla-
thrin-dependent endocytosis, caveolin-mediated en-
docytosis, and macropinocytosis, respectively.8 After a
3 h incubation with the cell lines and multiple washes,
Figure 2. NPC1 knockout inhibits C32122-mediated DNA transfection of MEFs.NPC1þ/þ and NPC1/MEFs were incubated
for 3 h with various doses of C32122 polyplexes containing GFP-encoding plasmid DNA, and GFP expression was assessed
by ﬂuorescence microscopy and FACS after 24 h. (a) Representative images showing decreased GFP expression in NPC1/
MEFs relative to wild-type MEFs, and FACS analysis of (b) GFP expression eﬃciency and (c) geometric mean ﬂuorescent
intensity (MFI) of GFP-expressing cells normalized to nontreated cells (mean ( SD, n = 4).
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we observed dramatically reduced uptake of cholera
toxin B in the NPC1-deficient cells (Figure 5a). Further-
more, transferrin uptake appeared to be slightly de-
creased and dextran uptake slightly increased.
Quantification of these experiments by FACS analysis
corroborated these trends (Figure 5b). When we com-
pared NPC1-deficient cells to wild-type cells, cholera
toxin B internalization was reduced ∼2030-fold;
transferrin uptake was reduced about 2-fold; and
dextran uptake was increased by ∼50%.
To determine whether PBAE polyplexes share com-
mon uptake pathways with these markers during
endocytosis, we incubated the C32122 polyplexes
containing labeled DNA in the presence of each one
of these markers and used confocal microscopy to
characterize the extent of colocalization in wild-type
MEFs at various time points. Although there was
evidence of DNA colocalization with all three markers,
the greatest extent of colocalization occurred with
cholera toxin B (Figure 6). These results suggest that
PBAE polyplexes and cholera toxin B rely on common
uptake pathways for internalization.
Studies with CHO Cell Lines Varying in NPC1 Expression. To
further elucidate the effects of NPC1, we examined
C32122/DNA uptake and transfection in chinese
hamster ovary (CHO) epithelial cell lines with varying
NPC1 expression (Figure 7). These cell lines included
wild-type CHO cells, NPC1-deficient CHO cells (null),
CHO cells expressing NPC1 with a mis-sense mutation
in the sterol-sensing domain resulting in defective
Figure 4. Eﬀects of NPC1 knockout on internalization of DNA inMEFs following transfection with C32122, PEI, and LF 2000.
NPC1þ/þ and NPC1/ MEFs were incubated with various doses Cy5-labeled plasmid DNA complexed with C32122,
polyethylenimine, or Lipofectamine 2000. After 3 h, the cells were washed, ﬁxed, and analyzed by FACS to determine (a) DNA
uptake eﬃciency (mean ( SD, n = 4) and (b) geometric mean Cy5 ﬂuorescent intensity normalized to nontreated cells
(mean ( SD, n = 4).
Figure 3. NPC1 knockout inhibits C32122-mediated internalization of DNA in MEFs. NPC1þ/þ and NPC1/ MEFs were
transfected with various doses of C32122 polyplexes containing Cy3-labeled plasmid DNA (green). After 3 h, the cells were
washed, ﬁxed, treated with the nuclear stain Hoescht (blue), and analyzed by high-throughput confocal microscopy.
(a) Representative images showing inhibitionof uptake inNPC1/MEFs, and (b) quantiﬁcationofDNAuptake (mean( SD,n=3).
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cholesterol trafficking44 (P692S) and wild-type CHO
cells stably overexpressing human NPC145 (hNPC1).
As was observed with the immortalized MEFs, NPC1
deficiency in CHO cells inhibited both DNA uptake and
transfection mediated by C32122. In the P692S CHO
cells, uptake and transfectionwere inhibited to a nearly
identical extent as the null cells, confirming the specific
dependence onNPC1's cholesterol-trafficking function
for PBAE-mediated gene delivery. Surprisingly, we
observed increased C32122-mediated DNA uptake
and transfection in the CHO cells stably overexpressing
humanNPC1 (Figure 7). These cells have been reported
to have a 1.5-fold increase in total cellular cholesterol
and a 2.9-fold increase in cholesterol at the plasma
membrane.45 It is possible that increased cholesterol
localization at the plasmamembranemay enhance the
activities of certain endocytic mechanisms used by
PBAE/DNA nanoparticles. These observations raise
the possibility of modulating key cellular factors to
improve nonviral gene delivery.
DISCUSSION
Although research within the nonviral gene delivery
ﬁeld continues to focus on materials engineering, the
rational design of more advanced nanocarriers will
Figure 5. NPC1 knockout alters relative endocytic pathway activities in MEFs. (a) MEFs were incubated for 3 h with media
containing various AF647-labeled (red) markers: 50 μg/mL transferrin (left), 55 ng/mL cholera toxin B (middle), or 100 μg/mL
10 000 MW dextran (right), traditional markers of clathrin-dependent, endocytosis, caveolae-mediated endocytosis, and
macropinocytosis, respectively. After 3 h, the cells were washed, ﬁxed, treated with the nuclear stain Hoescht (blue), and
analyzed by high-throughput confocal microscopy. (b) MEFs were incubated for 3 h with media containing various doses of
transferrin, cholera toxin B, or dextran, each labeledwithAF647.After 3 h, the cellswerewashedandﬁxed, and relativeuptake
was assessed by FACS as the geometric mean AF647 ﬂuorescent intensity normalized to nontreated cells (mean( SD, n = 4).
Figure 6. Colocalization of internalized DNA delivered by
C32122 with markers of distinct endocytic pathways in
MEFs. NPC1þ/þ MEFs were transfected with C32122 poly-
plexes containing Cy3-labeled DNA in the presence of
AF647-labeled (a) 55 ng/mL cholera toxin B or (b) 50 μg/mL
transferrin. After 3 h, the cells were washed, ﬁxed, treated
with the nuclear stain Hoescht (blue), and analyzed by
confocal microscopy for intracellular colocalization of DNA
(green) with each marker (red).
Figure 7. C32122-mediated DNA uptake and transfection
in CHO cell lines varying in NPC1 expression. CHO cells
varying in NPC1 expression were incubated for 3 h with the
indicated doses of (a) Cy5-labeled plasmid DNA or (b) GFP-
encoding plasmid DNA complexed with C32122 polymer.
FACS analysis was used to assess the (a) geometric mean
Cy5 ﬂuorescent intensities (MFI) of treated cells relative to
nontreated cells immediately after washing or (b) GFP
geometric MFI of treated cells relative to nontreated cells
after 24 h (mean ( SD, n = 4).
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likely beneﬁt from a deeper understanding of the
cellular mechanisms involved in nanoparticle interna-
lization and transfection. Toward this end, we exam-
ined the uptake of a promising class of degradable
cationic polymers, PBAEs, using a variety of tools
including pharmacological pathway inhibitors, labeled
uptake markers, and gene knockout cell lines. The
inhibitor experiments identiﬁed dynasore and U18666A
as suppressors of polyplex internalization in a mouse
embryonicﬁbroblast cell line (Figure 1). Dynasore inhibits
a broad set of dynamin-dependent pathways including
clathrin-mediated and caveolae-mediated endocytosis,
suggesting that PBAEs may use more than one pathway
to enter these cells. U18666A is an amphipathic steroid
with multiple actions, inhibiting both the synthesis of
cholesterol4649 and its traﬃcking from late endosomes
and lysosomes to the plasma membrane and the en-
doplasmic reticulum.5052 It has also beenwidely studied
as ameans of inducing amodel of Niemann-Pick type C1
disease5355 and may directly interact with and inhibit
the sterol-sensing site of the NPC1 protein.54,56,57
NPC1 is a 13 transmembrane protein present on the
late endosomes responsible for the egress of choles-
terol from cells. NPC1 has recently been identiﬁed as
an essential factor involved in endosomal escape of
certain ﬁloviruses,58,59 yet its absence improves the
retention and eﬃcacy of lipid/siRNA nanoparticles.6
Examination of NPC1-deﬁcient MEFs indicates that
NPC1 plays a signiﬁcant role in gene transfection and
uptake by poly(β-amino ester)s such as C32122 but
only a minor one in DNA internalization by PEI and LF
2000 (Figures 24). We demonstrate that NPC1 knock-
out in MEFs signiﬁcantly alters normal activities of
various endocytic pathways, with dramatically de-
creased caveolae-mediated endocytosis, slightly re-
duced clathrin-mediated endocytosis, and slightly
upregulatedmacropinocytosis (Figure 5). This observa-
tion is supported by examination of marker colocaliza-
tion experiments, which indicate that while PBAE/DNA
polyplexes likely use multiple mechanisms to enter
MEFs, caveolae-mediated endocytosis was the primary
route (Figure 6).
Both CHO cells that are devoid of NPC1, or stably
express NPC1 with a mutated sterol-sensing domain,
led to decreases in uptake and transfection eﬃciency
of PBAEs, further supporting our previous observation
that cholesterol transport signiﬁcantly impacts gene
delivery (Figure 7). Although reduced uptake was
identiﬁed as one factor in the diminished transfec-
tion eﬃciency of NPC1-deﬁcient cells, NPC1 may also
contribute to downstream steps such as endosomal
escape and/or nuclear transport of the polyplexes since
a 3-fold decrease in uptake led to a 10-fold decrease in
transfection eﬃciency in CHO cells (Figure 7).
Because NPC1 plays a role in regulating the traﬃck-
ing of cholesterol and because cholesterol has been
shown to be critically involved in both caveolin- and
clathrin-mediated endocytosis,6064 we had hypothe-
sized that NPC1 knockout would aﬀect these pro-
cesses. To our knowledge, although NPC1 knockout
has been associated with altered intracellular localiza-
tion of cholera toxin B and lactosylceramide
(LacCer),56,65 two markers of caveolin-mediated endo-
cytosis, and with defective recycling of transferrin
receptor,66 quantitative analysis of uptake for multiple
endocytic markers has not yet been reported. Despite
previous reports that ﬂuid-phase uptake of horseradish
peroxidase is impaired in NPC1 knockout cells67,68 or
cause no change in macropinocytosis-based internali-
zation, our results indicate that macropinocytic inter-
nalization of dextran is slightly increased in NPC1-
deﬁcient cells. Additionally, these results provide
further perspective on earlier work by our group
suggesting that lipid/siRNA nanoparticles are retained
in cells longer in NPC1-deﬁcient cells due to defects in
recycling, despite being internalized by macropinocy-
tosis. In contrast to both PBAE/DNA nanoparticles
(which likely enter via caveolae) and lipid/siRNA nano-
particles (which enter via macropinocytosis),6 choles-
terol in general enters through the clathrin-dependent
pathway and exits the late endosomes via NPC1-
mediated traﬃcking.69
CONCLUSIONS
The investigation of nonviral DNA transfection of
NPC1-deﬁcient cells reported here demonstrates the
importance of cholesterol traﬃcking for certain deliv-
ery formulations such as poly(β-amino ester)s. In this
study, one of the most striking observations was that
stable overexpression of NPC1 signiﬁcantly improved
DNA internalization and transfection by PBAEs
(Figure 7). These ﬁndings raise the tantalizing prospect
of enhancing nonviral gene delivery through active
modulation of cellular factors known to play key roles
in internalization, intracellular traﬃcking, or endo-
somal progression such as lysobisphosphatidic acid,
Rab5, and perhaps NPC1. Manipulation of NPC1 or
other such targets would of course need to be per-
formed in a manner that is speciﬁc, targeted, and
temporary and, due to the potential risks, would likely
only be considered for patients suﬀering from genetic
disorders for which there is no current viable therapy.
MATERIALS AND METHODS
Materials. 1,4-Butanediol diacrylate and 5-amino-1-pentanol
were purchased from Alfa Aesar (Ward Hill, MA, USA).
Dodecylamine was purchased from Sigma-Aldrich (St. Louis,
MO, USA). (PEO)4-bisamine (“122”) was acquired fromMolecular
Biosciences (Boulder, CO, USA). All chemical reagents were used
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without further purification. Plasmids encoding green fluores-
cent protein (gWiz-GFP) and firefly luciferase (gWiz-Luc) were
purchased from Aldevron (Fargo, ND, USA). jetPEI (Polyplus
Transfection, Illkirch, France) and Lipofectamine 2000 were
purchased from VWR (Radnor, PA, USA) and Invitrogen
(Carlsbad, CA, USA), respectively. Transferrin, cholera toxin B,
and 10 000MWdextran, each labeled with AlexaFluor 647, were
purchased from Invitrogen. Cytochalasin D, dynasore hydrate,
chlorpromazine hydrochloride, filipin III, genistein, methyl-β-
cyclodextrin, 5-(N-ethyl-N-isopropyl)amiloride, and U18666A
were obtained from Sigma-Aldrich. Immortalized mouse em-
bryonic fibroblast cell lines were cultured in DMEM (Invitrogen)
supplemented with 10% fetal bovine serum (Invitrogen).
Polymer Synthesis. To synthesize C32122, acrylate-terminated
C32 poly(β-amino ester) was first prepared in a 5 g batch by
reacting 1,4-butanediol diacrylate (“C”) and 5-amino-1-pentanol
(“32”) (1.2:1.0 diacrylate/amine molar ratio) without solvent at
90 C for 24 h with stirring. After cooling to room temperature
and dissolving the polymer in 10 mL of anhydrous THF, it was
added to a vial containing 10mmol of (PEO)4-bisamine (10mmol
in 40mL of anhydrous THF). Following overnight stirring at room
temperature, the amine end-modified polymer was purified
by precipitation in anhydrous diethyl ether (1:3 v/v THF/ether)
and dried under vacuum for 24h. C32122was thendissolved at
100 mg/mL in dimethyl sulfoxide (DMSO) and stored at 20 C
with desiccant until use.
DNA Transfection Experiments. One day before transfection,
cells (100 μL) were seeded into each well of a 96-well polystyr-
ene tissue culture plate (HeLa: 12 500 per well; MEFs: 9000 per
well). For studies using the pharmacological inhibitors, condi-
tioned medium was removed 1 h prior to transfection and
replaced with fresh, prewarmed medium containing the indi-
cated concentration of pharmacological inhibitor. For GFP
transfection experiments, gWiz-GFP (5 mg mL1) was diluted
to 160 μg mL1 in 25 mM sodium acetate (NaOAc) buffer at pH
5.2; for DNAuptake experiments, gWiz-Lucwas labeledwith Cy3
or Cy5 using the LabelIt kit (Mirus, Madison, WI, USA) following
themanufacturer's instructions andwas diluted inNaOAc buffer
as above. PBAEs (100mgmL1) were thawed immediately prior
to transfection and diluted in NaOAc buffer to a concentration
of 3.2mgmL1 (20:1w/w polymer/DNA). To formDNApolymer
nanoparticles, polymer solution (200 μL) was added to the
diluted DNA (200 μL), mixed by repeated pipetting, and allowed
to incubate for 10 min at room temperature. Depending on
the dose, polymerDNA complexes were diluted in NaOAc as
needed, and thenwere gentlymixed in a deep 96-well plate with
prewarmed fresh medium (360 μL). For inhibition experiments,
this medium was prepared with the indicated concentration of
pharmacological inhibitor, whereas for colocalization experi-
ments, labeled transferrin, cholera toxin B, or dextran were
present. Conditioned medium was removed using a 12-channel
aspirating wand and replaced with the complexes diluted in
medium (100 μL). jetPEI and Lipofectamine 2000 were used
according to the manufacturers' protocols.
For GFP transfection experiments, following a 3 h incuba-
tion at 37 C, complexes were removed with the aid of a
multichannel aspiration wand and replaced with fresh medium
(100 μL), and the cells were analyzed for GFP expression by
ﬂuorescence-activated cell sorting after 24 h at 37 C. For DNA
uptake experiments, cells were washed three times at the
indicated time point and prepared for analysis by either con-
focalmicroscopy (high-throughput or high-resolutionmicroscopy)
as previously described or using FACS.6
FACS Analysis. After aspirating conditioned medium and
washing cells three times with PBS, cells were detached using
25 μL per well of 0.25% trypsinEDTA (Invitrogen). Following a
5 min incubation at 37 C, fresh medium (50 μL) was added to
the cells, which were mixed thoroughly and then transferred to
a 96-well round-bottom plate. Cells were then pelleted, resus-
pended in fixation buffer (4% v/v formaldehyde in PBS), incu-
bated for 10 min at room temperature, pelleted again, and
finally resuspended in ice-cold FACS running buffer (2% v/v FBS
in PBS) containing 1:200 v/v propidium iodide (Invitrogen). The
cells were kept at 4 C until FACS analysis using a BD LSR II
(Becton Dickinson, San Jose, CA, USA). Except for experiments
with Cy3-labeled DNA, propidium iodide (PI) staining was used
to exclude dead cells from the analysis. PI stainingwas also used
to determine the viabilities of treated cells relative to non-
treated control cells, where the relative viability was calculated
as the ratio of live (unstained) treated cells per well to the mean
number of live nontreated cells per well. For GFP expression
analysis, 2D gating was used to separate increased autofluo-
rescence signals from increased GFP signals to more accurately
count positively expressing cells. Gating and analysis were
performed using FlowJo v8.8 software (TreeStar, Ashland, OR,
USA). Geometric mean fluorescent intensities of transfected
cells were normalized to those of the corresponding nontrans-
fected control cells.
Statistics. Data are expressed as mean( SD for groups of at
least three replicates. Data in Figure 1a,b were analyzed for
statistical significance by one-way ANOVA with Bonferroni
multiple comparison correction. Differences between drug-
treated and control groups in Figure 1c were analyzed for
statistical significance by unpaired, two-tailed Student's t test
with 95% confidence. Statistical tests were implemented in
GraphPad Prism 5 (*p < 0.05, **p < 0.01, and ***p < 0.001).
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